Cross is a globally recognized leader in funds finance, acting for lenders, borrowers and fund sponsors in subscription credit facilities, NAV facilities, hybrids and management fee loans.
High-profile panelists examined a range of issues surrounding women’s progression into leadership roles.
Cadwalader Represents The Medicines Company in Agreement to Divest Three of its Marketed Cardiovascular Products
Divestiture to Chiesi Farmaceutici S.p.A. valued up to $792 million for three marketed cardiovascular products and related assets.
A team led by Paul Pantano, Chad Mills and Kathryn Shurin advised Phibro in its acquisition of SG Solutions’ clean coal gasification plant near West Terre Haute, Indiana.
Cadwalader Represents The Medicines Company in Private Offering of $402,500,000 Convertible Senior Notes Due 2023
The team was led by Gregory Patti, Adam Summers, Daniel Zimmerman, Alexandra Cotter, Saadia Ghazi, Ray Shirazi and Nick Allen.
The firm advised the International Swaps and Derivatives Association in publishing documents that help market participants comply with new margining requirements for non-cleared derivatives.
The firm's Greater China team received the 2015 China Business Law Journal “China Business Law Award for Private Equity and Venture Capital.”
“The Day After Brexit” - A Discussion About the Legal Questions Now That Britain Has Voted to Leave the EU
Our webinar discusses the immediate legal questions companies will need to examine.